• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience

The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next
  • collapse Corapcioglu The effect of Quetiapine in chronic PTS
  • collapse Fast Titration Schizophrenia Italy
  • collapse AKA SA-SEA-0005, Seroquel Schiz IR plus Off-label
  • collapse Awad Seroquel. vs Olanzapine.
  • collapse Acute Mania Adjunct Treatment
  • collapse A mutlicentre, double blind randomised study to compare the safety, tolerability and efficacy of quetiapine and risperidone in the treatment of schizophrenia in patients previously treated with antipsychotic medication with inadequate symptom control.IRIS - Improved response in Schizophrenia.
  • collapse Open label Positron Emission Tomography study with [11C]AZD2995 and [11C]AZD2184, candidate radioligands for Aß amyloid, to determine and compare in vivo brain uptake and distribution in healthy volunteers and patients with Alzheimer's Disease
  • collapse An open-label prospective study to investigate the safety, efficacy and tolerability of quetiapine in adolescents and adults experiencing their first psychotic episode in and Australian Health Care Setting.
  • expand Quetiapine augmentation in the treatment of Depression
    Study Id
    AU-SEA-0004
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    AU-SEA-0004
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • collapse A piot study to examine the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa (AN) in young people.
  • Pages
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013